REFERENCES 1. Adeniyi B.A, Odelola H.A and Oso

121
REFERENCES
1. Adeniyi B.A, Odelola H.A and Oso B.A, (1996), “Antimicrobial potential of
Diospyros mesiliforus (Ebenaceae)” Afr. J. of Medical Sci, Vol. 25, pp. 221-224.
2. Akerle O.V and Heywood H.S, (1991), The conservation of medicinal plants,
Cambridge University Press, Cambridge.
3. Aly A and Scand J, (1987), “Prostaglandins in Clinical Treatment of Gastroduodenal
Mucosal Lesions: A Review” Gastroenterology, Vol. 22 (137), pp. 43–49.
4. Askenase P.W and Van Loveren M, (1983), “Delayed type hypersensitivity
inactivation of mast cells by antigen specific T-cells factors initiates cascade of
cellular interactions” Immunology Today, Vol. 4, pp. 259-264.
5. Baker D.D, Chu M, Oza U and Rajgarhia V, (2007), “The value of natural products
to future pharmaceutical discovery” Nat. Prod. Rep, Vol. 24, pp. 1225–1244.
6. Balkwill F and Mantovani A, (2001), “Inflammation and cancer: back to Virchow?”
The Lancet, Vol. 357 (9255), pp. 539-545.
7. Balkwill F.R and Mantovani A, (2012), “Cancer-related inflammation: common
themes and therapeutic opportunities” Semi Cancer Biol, Vol. 22(1), pp. 33-40.
8. Barocelli E, Chiavarini M, Ballabeni V, Barlocco D, Vianello P, Dal Piaz V and
Impicciatore M, (1997), “Study of the antisecretory and antiulcer mechanism of new
indenopyridazinone derivative in rats” Pharmacol Res, Vol. 35 (5), pp. 487- 492.
9. Basu S, (2003), “Carbon tetrachloride-induced lipid peroxidation: eicosanoid
formation and their regulation by antioxidant nutrients”Toxicology, Vol. 189 (1), pp.
113-127.
10. Bauer A.W, Kirby W.M and Sherris J.C, (1966), “Antibiotic susceptibility testing by
a standardized single disk method” Am J Clin Pathol, Vol. 45, pp. 493-496.
122
11. Beckett H.H and Stenlake J.B, (1986), Practical Pharmaceutical Chemistry, 3rded,
Vol-II, pp. 74-95.
12. Bhattaram
V.A,
Graefe
(2002),“Pharmacokinetics
U,
Kohlert
C,
Veit
M
and
Derendorf
H,
and bioavailability of herbal medicinal products”
Phytomedicine, Vol. 9 (3), pp. 1-33.
13. Blaser M.J, Chyou P.H and Nomura A, (1995), “Age at establishment of
Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal
ulcer risk”Cancer research, Vol. 55 (3), pp. 562-565.
14. Borris R.P, (1996), “Natural products research: perspectives from a major
pharmaceutical company”J.Ethanopharmacol, Vol. 51(1-3), pp. 29-38.
15. Bostwick D.G and Brawer M.K, (1987), “Prostatic Intra-Epithelial Neoplasia and
Early Invasion in Prostate Cancer” Cancer, Vol. 59, pp. 788–794.
16. Bounatirou S, Smiti S, Miguel M.G, Falerio L, Rejeb M.N and Neffati M, (2007),
“Chemical composition, antioxidant and antibacterial activities of the essential oils
isolated from Tunisian Thymus capitatus Hoff. et Link” Food Chemistry, Vol. 105,
pp. 146-155.
17. Brattin W.J, Glend F.A and Recknagel R.O, (1985), “Pathological mechanism in
carbon tetrachloride hepatotoxicity” J Free Radical Boil Med, Vol. 1, pp. 27-28.
18. Butler M.S, (2008), Nat. Chem. Bio, Vol. 2, pp. 674-681.
19. Chandra P and Arora D.S, (2009), “Antioxidant activity of fungi isolated from soil
of different areas of Punjab India” Journal of Applied and Natural Science, Vol. 1,
pp. 123-128.
20. Chang L.W, Yen W.J, Huang S.C and Duh P.D, (2002), “Antioxidant activity of
sesame coat” Food Chemistry, Vol. 78, pp. 347-354.
123
21. Choi S, Kim K.W, Choi J.S, Han S.T, Part YI, Lee S.K, Kim J.S and Chung M.H,
(2002), “Angiogenic activity of β-sitosterol in the ischaemia/reperfusion-damaged
brain of Mongolian Gerbil” Planta Med, Vol. 68 (4), pp. 330–335.
22. Chung K.T, Wong T.Y, Wei C.I, Huang Y.W and Lin Y, (1998), “Tannins and
human health: a review” Crit. Rev. Food Sci. Nutr, Vol. 38 (6), pp. 421-464.
23. Comb R.B and Bowers G.N, (1972), “Study of optimum buffer conditions for
measuring alkaline phosphatase activity in human serum” Clin Chem, Vol. 18 (2),
pp.97-104.
24. Cossens L.M and Werb Z, (2002), “Inflammation and cancer” Nature, Vol. 420
(6917), pp. 860-867.
25. Da Rocha A.B, Lopes R.M and Schwartsmann G, (2001), “Natural products in
anticancer therapy” Current Opinion in Pharmacology, Vol. 1(4), pp. 364-369.
26. Dahanukar S.A, Kulkarni R.A and Rege N.N, (2000), “Pharmacology of medicinal
plants and natural products” Ind. J.of Pharmacol, Vol. 32, pp. 81-118.
27. Dashputre N.L and Naikwade N.S, (2010), “Immunomodulatory Activity of
Abutilon Indicum linn on Albino Mice”Int J Pharma Sci Res, Vol. 1 (3), pp. 178184.
28. Demain A.L, (1983), “New applications of microbial products” Science, Vol. 219,
pp. 709-714.
29. Desai P.D, Ganguly A.K, Govindachari T.R, Joshi B.S, Kamat V.N, Manmade A.H,
Mohamed P.A, Nagle S.K, Nayak R.H, Saksena A.K, Sathe S.S and Vishwanathan
N, (1966), “Chemical investigation of some Indian Plants.Part II” Indian J. Chem,
Vol. 4, pp. 457-459.
30. Diplock A, (1997), “Will the good fairies please prove to us that vitamin E lessens
human degenerative diease” Free Rad. Res, Vol. 27 (5), pp. 511-532.
124
31. Dunnet C.W, (1964), “New tables for multiple comparison with a control”
Biometrics, Vol. 20, pp. 482-491.
32. DvorakH.F, (1986), “Tumors: wounds that do not heal: similarities between tumor
stroma generation and wound healing”The New England journal of medicine, Vol.
315 (26), pp. 1650-1659.
33. Ecobichon D.J, (1997), The basis of toxicology testing, 2nd ed, Newyork, CRC press,
pp 43-46.
34. EhrkeM and Jane, (2003), “Immunomodulation in cancer therapeutics” International
immunopharmacology, Vol. 3 (8), pp. 1105-1119.
35. Ehrke M.J, Verstovsek S, Zaleskis G, Ho R.L, Uihazy P, Maccubbin D.L and
Mihich E, (1996),“Specific anti-EL4-lymphoma immunity in mice cured 2 years
earlier with doxorubicin and interleukin-2” Cancer Immunol Immunother,Vol.
42(4), pp. 221-230.
36. EmingS.A, KriegT and DavidsonJ.M, (2007), “Inflammation in wound repair:
molecular and cellular mechanisms”Journal of Investigative Dermatology, Vol. 127
(3), pp. 514-525.
37. Farooq S, Ahmed I and Pathak G.K, (1997), “Protective role of koflet (an Ayurvedic
preparation) against cellular toxicity caused by Carbon tetrachloride and flyash” J.
Ethnopharmacol, Vol. 53, pp. 109-116.
38. Fisher A.A and Le Couteur D.G, (2001), “Nephrotoxicity and hepatotoxicity of
histamine H2 receptor antagonists” Drug safety, Vol. 24(1), pp. 39-57.
39. Fulzele S.V, Satturwar P.M, Joshi S.B and Dorle A.K, (2003), “Study of the
immunomodulatory activity of Haridradl ghrita in rats” Ind. J Pharmacol, Vol. 35,
pp. 51-54.
40. Galighor A.E and Kozloff E.N, (1976), Essentials of practical microtechnique, 2nd
ed, Lea and Febiger, NewYork.
125
41. Gallo M.B and Sarachine M.J, (2009), “Biological activities of lupeol” Int J Biomed
and Pharmaceu Sci, Vol. 3, pp. 46-66.
42. Garodia P, Ichikawa H, Malani N, Sethi G and Aggarwal B.B, (2007),“From ancient
medicine to modern medicine: ayurvedic concepts of health and their role in
inflammation and cancer” J Soc Integr Oncol,Vol. 5 (1), pp. 25-37.
43. Gennaro A.R, (1995), The science and Practice of Pharmacy, 9th ed, Vol-1, Mac
publishing Company, Easton PA.
44. Georges M and Pandelai K.M, (1949), “Investigations on plant antibiotics. IV.
Further search for antibiotic substances in Indian medicinal plants” Indian J. Med.
Res, Vol. 37, pp. 169-181.
45. Goodman and Gilman, (1991), The pharmacological basis of therapeutics 6th edn,
McGraw Hill, London,pp. 145-147.
46. Goyal S.S, Patel R.M, Sukhramani P.S and Kamothi K.A, (2010), “A novel target
for cancer therapy” IJPSR, Vol. 1(4), pp. 1-21.
47. Grabley S and Sattler I, (2003), Natural products for lead identification: Nature is a
valuable resource for providing tools. In A. Hillisch and R. Hingenfeld (Eds.),
Modern Methods of Drug Discovery, Birkhäuser Verlag, Switzerland, pp 87-107.
48. Griswold D.E, Marshall P.J, Webb E.F, Godfrey R, Newton J, DiMartino M.J, Sarau
H.M, Gleason J.G, Poste G and Hanna N, (1987), “A structurally novel antiinflammatory agent that inhibits lipoxygenase and cyclooxygenase mediated
metabolism of arachidonic acid” Biochem Pharmacol, Vol. 36 (20), pp. 3463–3470.
49. Guth P.H, Paulsen G and Nagata H, (1984), “Histologic and microcirculatory
changes in alcohol-induced gastric lesions in the rat: effect of prostaglandin
cytoprotection” Gastroenterol, Vol. 87 (5), pp. 1083-1090.
126
50. Hafeez B, Haque R, Parvez S, Pandey S, Sayeed I and Raisuddin S, (2003),
“Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in
mice” Int Immunopharmacol, Vol. 3 (2), pp. 257-265.
51. HalterF,
Tarnawski
A.S,
Schmassmann
A
and
Peskar
B.M,
(2001),
“Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and
ulcer healing: controversial issues and perspectives”Gut, Vol. 49 (3), pp. 443-453.
52. Hammer K.A, Carson C.F and Riley T.V, (1999), “Antimicrobial activity of
essential oils and other plant extracts” Journal of Applied Microbiology, Vol. 86, pp.
985-990.
53. Harvey A.L, (2008), “Natural products in drug discovery” Drug discovery today,
Vol. 13 (19), pp. 894-901.
54. Hoffstein S.T, Weissmann G and Pearlstein E, (1981), “Fibonectin is a component
of the surface coat of human neutrophils” J. Cell Sci, Vol. 50 (1), pp. 315–327.
55. Hogg J.A, (1971), Upjohn Co, Kalamazoo, June 01, Mich. 49001, Drug Discovery
Chapter 2:14-32.
56. Holt G.A and Chandra A, (2002), “Herbs in the modern healthcare environment-An
overview of uses, legalities, and the role of the healthcare professional” Clin. Res.
Regulatory Affair (USA), Vol. 19, pp. 83-107.
57. Horbone J.B, (1984), Phytochemical methods, a guide to modern techniques of plant
analysis, II ed, Chapman and Hall, New York, pp. 85.
58. http://www.in.gov/isdh/17438.htm
59. Huang W.Y, Cai Y.Z, Hyde K.D, Corke H and Sun M, (2007), “Endophytic fungi
from Nerium oleander L (Apocynaceae): main constituents and antioxidant activity”
World Journal of Microbiology & Biotechnology, Vol. 23 (9), pp. 1253-1263.
60. Ivetic Tkalcevic V, Bosnjak B, Hrvacic B, Bosnar M, Marjanovic N, Ferencic and
Erakovic V, (2006), “Anti-inflammatory activity of azithromycin attenuates the
127
effects of lipopolysaccharide administration in mice” European journal of
pharmacology, Vol. 539 (1), pp. 131-138.
61. Iwu M.W, Angela R, Duncan and Chris O. Okunji, (1999), New antimicrobials of
plant origin. Perspectives on new crops and new uses, ASHS Press, Alexandria, VA,
457-462.
62. Jain S.M and Santani D.D, (1994), “Peptic ulcer disease and status of current drug
therapy” Indian Drugs, Vol. 31(9), pp. 395-400.
63. Jain V, Prasad V and Pandey R.S, (2006),“Wound healing activity of Desmodium
gangeticum in Different Wound Model” Journal of Plant Sciences, Vol. 1(3), pp.
247-253.
64. Janin Y.L, (2003), “Peptides with anticancer use or potential” Amino acids, Vol.
25(1), pp. 1-40.
65. Jarvis B.B, (2000), “Chapter One The role of natural products in evolution” Recent
Advances in Phytochemistry, Vol. 34, pp. 1-24.
66. Jendrassik L and Grof P, (1938), “Quantitative determination of total and direct
bilirubin in serum and plasma” Biochem, Vol. 297, pp. 81-89.
67. Johnston B.A, (1998), “Major diversity loss: 1 in 8 plants in global study
threatened” Herbal Gram, Vol. 43, pp. 54.
68. Jude E.O and Paul A, (2009), “Antiulcer and Anticonvulsant Activity of Croton
Zambesicus” J. Pharm. Sci, Vol. 22, pp. 384-390.
69. Kamboj V.P, (2000), “Herbal medicine” Current science, Vol. 78(1), pp. 35-51.
70. Karampetsou M.P, Liossis S.N and Sfikakis P.P, (2010), “TNF-α antagonists
beyond approved indications: stories of success and prospects for the future”Qjm,
Vol. 103(12), pp. 917-928.
128
71. Kharwar R.N, Mishra A, Gond S.K, Stierle A and Stierle D, (2011), “Anticancer
compounds derived from fungal endophytes: their importance and future challenges”
Natural Product Reports, Vol. 28(7), pp. 1208-1228.
72. Kim Y, Chung I, Ahn J, Lee H, Chen G, Manji H.K, Potter W.Z and Pickar D,
(1995), “Pharmacologic profile of natural products used to treat psychotic illnesses”
Psychopharmacol. Bull, Vol. 31 (1), pp. 139-145.
73. Kindt T.J and Kuby J, (2007), Kuby immunology, Macmillan.
74. Kokate C.K, (1991), Practical Pharmacognosy, III (Eds. Dinesh K Furia , N.)
Prakasan, Pune, pp. 122.
75. Konig P, Hordvik N.L and Kreutz C, (1987), “The preventive effect and duration of
action of nedocromil sodium and cromolyn sodium on exercise-induced asthma
(EIA) in adults” J. Allergy. Clin. Immunol, Vol. 79, pp. 64-68.
76. Krishna Mohan G, Pallavi E, Ravi Kumar B, Ramesh M and Venkatesh S, (2007),
“Hepatoprotective activity of Ficus carica Linn. leaf extract against carbon
tetrachloride-induced hepatotoxicity in rats” DARU, Vol. 15 (3), pp. 162-166.
77. Kritikar K.R and Basu B.D, (1993), Indian Medicinal Plants,Dehradun, India, Shiva
Publishers, Vol- 2.
78. Kroll D.J, (2001), “Concerns and needs for research in herbal supplement
pharmacotherapy and safety” J. of Herbal Pharmcother, Vol. 1 (2), pp. 3-23.
79. Kunchandy J, Khanna S and Kulkarni S.K, (1985), “Effect of alpha2 agonists
clonidine, guanfacine and B-HT 920 on gastric acid secretion and ulcers in rats”
Arch. Int. Pharmacodyn, Vol. 275 (1), pp. 123-138.
80. Kwek S.S, Cha E and Fong L, (2012), “Unmasking the immune recognition of
prostate cancer with CTLA4 blockade” Nature Reviews Cancer,Vol. 12 (4), pp. 289297.
129
81. Kwiecien S, Brzozowski T and Konturek S.J, (2002), “Effects of reactive oxygen
species action on gastric mucosa in various models of mucosal injury”Journal of
physiology and pharmacology, Vol. 53 (1), pp. 39-50.
82. Laine, Ahnen, Mcclain, Solcia and Walsh, (2000), “Potential gastrointestinal effects
of long-term acid suppression with proton pump inhibitors” Alimentary
Pharmacology & Therapeutics, Vol. 14, pp. 651–668.
83. Lang F, Keller K, Ihrig M, Oudtshoorn-Eckard J, Moller H, Srinivasan S and Yu H,
(2001), “Biopharmaceutical characterisation of herbal medicinal products”
Pharmazeutische Industrie, Vol. 63(10), pp. 1005-1010.
84. Lechler R.I, Sykes M, Thomson A.W and Turka L.A, (2005), “Organ
transplantation-how much of the promise has been realized?” Nature medicine, Vol.
11(6), pp. 605-613.
85. Lee J, Koo N and Min D.B, (2004), “Reactive oxygen species, aging and
antioxidative neutraceuticals” Comp Rev Food Sci Food Safety, Vol. 3, pp. 21-33.
86. Lewis W.H and Lewis M.P, (1995), “Medicinal plants as sources of new
therapeutics” Ann. Mo. Bot. Gard, Vol. 82, pp. 16-24.
87. Lotter K, Hocherl K, Bucher M and Kees F, (2006), “In vivo efficacy of
telithromycin on cytokine and nitric oxide formation in lipopolysaccharide-induced
acute systemic inflammation in mice” Journal of antimicrobial chemotherapy, Vol.
58 (3), pp. 615-621.
88. LuH, OuyangW and Huang C, (2006), “Inflammation, a key event in cancer
development”Molecular Cancer Research, Vol. 4 (4), pp. 221-233.
89. Luster M.L, Dean J.H and Boorman G.A, (1982), “Cell mediated immunity and its
application in Toxicology” Environmental Health Perspectives, Vol. 43, pp. 31-36.
90. Mann J, (2001), “Natural products as immunosuppressive agents” Natural product
reports, Vol. 18(4), pp. 417-430.
130
91. Mann J, (2002), “Natural products in cancer chemotherapy: Past, present and future”
Nat.Rev.Cancer, Vol. 2(2), pp. 143-148.
92. McCraken J.R and Chaikin M, (1974), “Polarity fractionation of solvent extracted
Wool Grease” Journal of the Textile Institute, Vol. 65(5), pp. 261.
93. Mehta R.G and Pezzuto J.M, (2002), “Discovery of cancer preventive agents from
natural products: from plants to prevention” Curr. Onol.Rep, Vol. 4(6), pp. 478-486.
94. Meir S, Kanner J, Akiri B and Hadas S.P, (1995), “Determination and involvement
of aqueous reducing compounds in oxidative defense systems of various senescing
leaves” J. Agric. Food Chem, Vol. 43, pp. 1813-1821.
95. Miles D.H, Nguyen C.L and Miles D.H, (1998),“Utilization of natural products for
treatment of blood diseases” Current medicinal chemistry, Vol. 5, pp. 421-440.
96. Mitra S.K, Venkataranganna M.V, Sundaram R and Gopumadhavan S, (1998),
“Protective effects of HD-03, a herbal formulation, against various hepatotoxic
agents in Rats” Ethnopharmacol J, Vol. 63 (3), pp. 181-186.
97. Mogensen T.H, (2009), “Pathogen recognition and inflammatory signaling in innate
immune defenses”Clinical microbiology reviews, Vol. 22 (2), pp. 240-273.
98. Mukerjee K.L, (1996), Medical Laboratory Technology MC Granohill, New Delhi,
1st ed, 674-675.
99. Muppayavarmath S.S and Patil P.A, (1999), “The influence of tricyclic
antidepressants on resutured incision and deep space wound healing” Indian J.
pharmacology, Vol. 31, pp. 290-293.
100. Myers N, Mittermeier R.A, Mittermeier C.G and Fonseca G.A, (2000), “Biodiversity
hotspots for conservation priorities” Kent J, Vol. 403, pp. 853–858.
101. Naik S.R and Dhiman R.K, (1993), “Peptic ulcer” Q.Med. Review, Vol. 44(1), pp.
1-15.
131
102. Narmato K, (1997), Infrared and Raman spectra of Inorganic and Coordination
compounds, Wiley Inter Science, IIIrd ed, New York. Pp. 296-346.
103. Nayak B.S, Sandiford S and Maxwell A, (2007), “Evaluation of the wound-healing
activity of ethanolic extract of Morinda citrifolia L” Evid Based Complement
Alternat Med, Vol. 6 (3), pp. 351–356.
104. Nayar M.P, (1996), Hot spots of Endemic plants of Inia, Nepal and Bhutan. Tropical
Botanical Garden and Research Institute, Palode, Thiruvanathapuram.
105. Neeraj D and Sharma S, (2007), “Food spoilage, food infections and intoxications
caused by microorganisms and methods for their detection” Food and Industrial
Microbiology, Vol. 25, pp. 1-42.
106. Nelson P.S and Montgomery B, (2003), “Unconventional therapy for prostate
cancer: good, bad or questionable?”Nature Reviews Cancer, Vol. 3 (11), pp. 845858.
107. Newman D.J and Cragg G.M, (2007), “Natural products as sources of new drugs
over the last 25 years” J. Nat. Prod, Vol. 70 (3), pp. 461–477.
108. Newman D.J, Cragg G.M and Snader K.M, (2003), “Natural Products as Sources of
New Drugs over the Period 1981-2002” J. Nat. Prod, Vol. 66, pp. 1022-1037.
109. Othman A, Ismail A, Ghani N.A and Adenan I, (2007), “Antioxidant capacity and
phenolic content of cocoa beans” Food Chemistry, Vol. 100, pp. 1523-1530.
110. Patra A.S, Jha P.N, Murthy, Manikier and Sharone A, (2010), “Isolation and
charactzation of stigmast-5-en-3β-ol (β-sitosterol) from the leaves of Hygrophila
spinosa T. Anders” Int. J. Pharm. Sci. Res, Vol. 1 (2), pp. 95-100.
111. Perera R.M and Bardeesy N, (2011), “Cancer: when antioxidants are bad”Nature,
Vol. 475 (7354), pp. 43-44.
112. Picman A.K, (1986), “Biological activity of sesquiterpene lactones” Biochem. Syst.
Ecol, Vol. 14, pp. 255-281.
132
113. Pihan G, Regillo C and Szabo S, (1987), “Free radicals and lipid peroxidation in
ethanol aspirin induced gastric mucosa injury” Dig. Dis. Sci, Vol. 32 (12), pp. 13951401.
114. Piper D.W and Stiel D.D, (1986), “Pathogenesis of chronic peptic ulcer, current
thinking and clinical Implications” Medical Progress, Vol. 2, pp. 7-10.
115. Pradhan D, Kakkar N, Bal A, Singh S.K and Joshi K, (2009), “Sub-typing of renal
cell tumours, contribution of ancillary techniques” Diagnostic Pathology, Vol. 4, pp.
21.
116. Prakasha H.M, Krishnappa M, Krishnamurthy Y.L and Poornima S.V, (2010),“Folk
medicine of NR PuraTaluk in Chikamaglur district of Karnataka” Indian Journal of
Traditional Knowledge, Vol. 9(1), pp. 55-60.
117. Prasad V, Jain V and Dorle A.K, (2006), “Evaluation of Momordica charantia ghrita
for immunomodulatory activity” J. Plant Sci, Vol. 1, pp. 80-85.
118. Rainsford, K.D, (1984), Adv. Inflamm. Res, Vol. 6, pp. 51–64.
119. Raitman S and Frankel S, (1957), “A colorimetric method for the determination of
serum glutaminic oxaloacetic and glutamic pyruvic transaminase” Am J. Clin.
Pathol, Vol. 28, pp. 56-63.
120. Raju D, (2009), “Evaluation of Anti-ulcer activity of methanolic extract of
Terminalia chebula fruits in experimental rats” J. Pharm. Sci. & Res, Vol. 1 (3), pp.
101-107.
121. Rao K.S and Mishra S.H, (1997), “Screening of anti-inflammatory and
hepatoprotective aactivities of alantolactone isolated from the roots of Inula
racemosa” Indian Drugs, Vol. 34 (10), pp. 571-575.
122. Ray A, Banerjee B.D and Sen P, (1996), “Modulation of humoral and cell mediated
immune responses by Azadirachta indica in mice” Ind J Exp Biol, Vol. 34, pp. 698–
701.
133
123. Recknage R.O, Glender E.A and Walter R.L, (1989), “Mechanism of Carbon
tetrachloride toxicity” Pharmal ther, Vol. 43, pp. 139-154.
124. Romano M and Cuomo A, (2004), “Eradication of Helicobacter pylori: a clinical
update” Medscape General Medicine, Vol. 6(1), pp. 19-25.
125. Rous P, (1910), “A transmissible avian neoplasm.(Sarcoma of the common fowl)”
The journal of experimental medicine,Vol. 12 (5), pp. 696-705.
126. Sakat S.S and Juvekar R.A, (2009), “Antiulcer Activity of Methanol Extract of
Erythrina indica Lam. Leaves in Experimental Animals” Pharmacognosy Research,
Vol. 1 (6), pp. 396-401.
127. Scazzocchio F, Cometa M.F, Tomassini L and Palmery M, (2001), “Antibacterial
activity of Hydrastis Canadensis extract and it’s major isolated alkaloids” Planta.
Med, Vol. 67, pp. 561-563.
128. Sehgal S.N, (2003), “Sirolimus: its discovery, biological properties, and mechanism
of action” In Transplantation proceedings, Vol. 35(3), pp. 7-14.
129. Sharma A, Lal K and Handa S.S, (1992), “Herbal Drug Standardization: HPLC
Determination of Vasicine in Polyherbal Formulations” Int. J. Pharmacognosy, Vol.
30, pp. 205–208.
130. Sharma S and Sikarwar M.S, (2008), “Wound healing activity of ethanolic extract
of leaves of Eclipta alba” Pharmacognosy Magazine, Vol. 4 (13), pp. 108-111.
131. Shay H, Komarov S.A, Fels S.S, Meranze D, Gruenstein M and Siplet H, (1945),
“A simple method for uniform production of gastric ulceration in the rat”
Gastroenterology, Vol. 5, pp. 43-61.
132. Shetty B.V and Kaveriappa K.M, (1991), The Western Ghats – Need for
Preservation
in
and
Kodagu,
Mangalore
Mangalagangothri, Karnataka. 258-272.
University,
Decennial
volume,
134
133. Shu Y.Z, (1998), “Recent natural products based drug development: a
pharmaceutical industry perspective” Journal of natural products, Vol. 61(8), pp.
1053-1071.
134. Shwetha R. Ballal, Rama Bhat P, Sumalatha and Sadananda Acharya, (2012),
“Studies on Immunostimulatory Effect of Pajanelia longifolia (willd) Schumann on
Albino Rats” International Journal of Research in Pharmaceutical and Biomedical
Sciences, Vol. 3(4), pp. 1642-1651.
135. Silva M.T, Silva M.N and Appelberg R, (1989), “Neutrophil-macrophage
cooperation in the host defence against mycobacterial infections” Microb. Pathog,
Vol. 6, pp. 369-380.
136. Smith M.G, Hold G.L, Tahara E and El-Omar E.M, (2006), “Cellular and molecular
aspects of gastric cancer”World Journal of Gastroenterology,Vol. 12 (19), pp. 2979.
137. Sneader W, (1996), Drug Prototypes and Their Exploitation, Wiley, UK.
138. Srivastava S, Verma R.K, Gupta M.M and Kumar S, (1999), “Reversed Phase HPLC
Determination of 1,3-benzodioxanes in P. mullesua” J. Chromatogr. & Rel.
Technol, Vol. 841, pp. 123–126.
139. Sun B and Karin M, (2012), “Obesity, inflammation, and liver cancer”Journal of
hepatology, Vol. 56 (3), pp. 704-713.
140. Szabo S, Pihan G and Regillo C, (1987), “Free radicals and lipid peroxidation in
ethanol aspirin induced gastric mucosa injury” Dig. Dis. Sci, Vol. 32 (12), pp. 13951401.
141. Tamayo R.P, (1983), “Is Cirrhosis of the Liver Experimentally Produced by CC14 an
Adequate Model of Human Cirrhosis?”Hepatology, Vol. 3 (1), pp. 112-120.
142. Toyota M and Asakawa Y, (1999), “Sesquiterpenoids and cyclic bis (bibenzyls)
from the Pakistani Liverwort Plagiochasma appendiculatum” J Hattori Botanical
Laboratory, Vol. 86, pp. 161–167.
135
143. Treadway S, (1998), “An Ayurvedic herbal approach to a healthy liver”Clin Nutr
Insights, Vol. 6 (16), pp. 1-3.
144. Venkumar M.R and Latha M.S, (2002), “Hepatoprotective effect of the methanoic
effect of the orchids in Carbontetrachloride treated male rats” J.Pharmacol, Vol. 34,
pp. 2.
145. Vicente M.F, Basilio A, Cabello A and Pelaez F, (2003), “Microbial natural products
as a source of antifungals” Clinical microbiology and infection, Vol. 9(1), pp. 15-32.
146. Wagnar G and Blatt S, (1996), Plant drug analysis, a thin layer chromatography
atlas 2nd ed, Springer Verlog, pp. 352-355.
147. Wagner
H,
(1990),
“Search
for
plant
derived
natural
products
with
immunostimulatory activity” Pure and Appl. Chem, Vol. 62 (7), pp. 1217-1222.
148. Wilkinson P.C, Vane J.K and Ferreria S.H, (1978), Handbook of experimental
pharmacology, Berlin, Springer Verlog, pp.109.
149. Wiseman H and Halliwell B, (1996), “Damage to DNA by reactive oxygen and
nitrogen species: role in inflammatory disease and progression to cancer”Biochem.
J,Vol. 313, pp. 17-29.
150. Zhao R, Xiang Z.J, Ye T.X, Yaun J.Y and Guo X. Z, (2006), “Antioxidant activities
of Salvia miltiorrhiza and Panax notoginseng” Food Chemistry, Vol. 99, pp. 767774.
151. Zhu K, Sauer J.R, Bowman A.S andDillwith J.W, (1997), “Identification and
characterization of anticoagulant activities in the saliva of the lone star tick,
Amblyomma americanum (L)” The Journal of parasitology, pp. 38-43.
136
PUBLICATIONS
LIST OF PUBLICATIONS IN JOURNALS:
1. Vinothapooshan G and Sundar K, (2011), “Immunomodulatory Activity of Various
extracts of Adhatoda vasica Linn. In experimental rats” African Journal of
Pharmacy and Pharmacology, Vol.5 (3), pp. 306-310.
2. Vinothapooshan G and Sundar K, (2010), “Wound Healing effect of various
extracts of Mimosa pudica” Pharmacologyonline,Vol. 1, pp. 307-315.
3. Vinothapooshan G and Sundar K, (2010), “Hepatoprotective activity of Adhatoda
vasica leaves against carbontetrachloride induced toxicity” Pharmacologyonline,
Vol. 2, pp. 551-558.
4. Vinothapooshan G and Sundar K, (2010), “Wound Healing effect of various
extracts of Adhatoda vasica” International Journal of Pharma and Bio
Sciences,Vol. 1(4), pp. 530-536.
5. Vinothapooshan G and Sundar K, (2010), “Anti-ulcer activity of Mimosa pudica
leaves against gastric ulcer in rats” Research journal of Pharmaceutical, Biological
and chemical Sciences, Vol. 1(4),pp. 606-614.
137
Curriculum Vitae
Mr. G. Vinothapooshan is currently working as an Assistant professor at Arulmigu
Kalasalingam College of Pharmacy, Krishnankoil, India. Mr. Vinothapooshan obtained
his Bachelor of Pharmacy degree from Arulmigu Kalasalingam College of
Pharmacyaffiliated to Tamilnadu Dr. M.G.R Medical University, Chennai and Master
of Pharmacy in Pharmaceutics from J.S.S. College of Pharmacy, Ooty affiliated to
Tamilnadu Dr. M.G.R Medical University, Chennai. He has authored 15 peer-reviewed
research articles and presented more than 20 research papers in National and
International conferences. His research interests include exploration of natural products
for various pharmacological activities.

Download Report